Evidence map›Paper›PMID 40883276›Full record

ArticleBlood cancer journal2025

Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study.

Adrian Wong, Victor H Jimenez-Zepeda, Kathryn Rankin, Irwin Sandhu, Michael Chu, Aurélien Delluc, Hira Mian, Julie Stakiw, Christopher Cipkar, Arleigh McCurdy and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Adrian WongUniversity of Ottawa, Ottawa, ON, Canada.ORCID http://orcid.org/0009-0002-1454-8424
Victor H Jimenez-ZepedaArnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.
Kathryn RankinDepartment of Oncology, Cross Cancer Institute, University of Alberta Edmonton, Ottawa, AB, Canada.
Irwin SandhuDepartment of Oncology, Cross Cancer Institute, University of Alberta Edmonton, Ottawa, AB, Canada.
Michael ChuDepartment of Oncology, Cross Cancer Institute, University of Alberta Edmonton, Ottawa, AB, Canada.
Aurélien DellucDivision of Hematology, The Ottawa Hospital, Ottawa, ON, Canada.
Hira MianDepartment of Oncology, McMaster University, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0003-1584-1067
Julie StakiwSaskatoon Cancer Clinic, Saskatoon, SK, Canada.
Christopher CipkarDivision of Hematology, The Ottawa Hospital, Ottawa, ON, Canada.
Arleigh McCurdyDivision of Hematology, The Ottawa Hospital, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0002-8809-4368
Benjamin PatrickDivision of Hematology, The Ottawa Hospital, Ottawa, ON, Canada.ORCID http://orcid.org/0009-0007-4811-3759
Sarah AlbertDivision of Hematology, The Ottawa Hospital, Ottawa, ON, Canada.
Meriem HeniaUniversity of Ottawa, Ottawa, ON, Canada.
Edward KooDivision of Hematology, The Ottawa Hospital, Ottawa, ON, Canada.
Hyra SapruDivision of Hematology, The Ottawa Hospital, Ottawa, ON, Canada.
Christopher McCuddenDepartment of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada.
Alissa VisramDivision of Hematology, The Ottawa Hospital, Ottawa, ON, Canada. visrama@hhsc.ca.ORCID http://orcid.org/0000-0002-7201-4642

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40883276
PMCPMC12397400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.